Neuren Pharmaceuticals Limited ( (AU:NEU) ) has shared an update.
Neuren Pharmaceuticals Limited has announced an update on its ongoing share buy-back program, with a total of 78,353 securities bought back on the previous day, adding to the cumulative total of 1,151,796 securities repurchased. This buy-back initiative reflects the company’s strategic efforts to manage its capital structure and potentially enhance shareholder value.
More about Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of therapies for neurological disorders. The company is listed on the Australian Securities Exchange under the code NEU.
YTD Price Performance: 0.01%
Average Trading Volume: 590
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $997.8M
Find detailed analytics on NEU stock on TipRanks’ Stock Analysis page.